MoneyWorks4Me

Kopran informs about credit rating

04 Jun 2021 Evaluate

Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Regulations’), Kopran has informed that CRISIL has assigned rating, as details is attached. Further, pursuant to Regulation 30(8) of the SEBI Regulations, this intimation will also made available on the Company’s website at www.kopran.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..